Recovery from depression

Psychiatric Clinics of North America

Volumn 35, Issue 1, 2012, Pages 37-49

  Stotland, Nada L ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

Depression; Recovery; Remission; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT;

AGE; ATTITUDE TO HEALTH; BIPOLAR DISORDER; CLINICAL FEATURE; COGNITION; COGNITIVE THERAPY; COMORBIDITY; CONVALESCENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOCTOR PATIENT RELATION; ELECTROENCEPHALOGRAM; HEALTH CARE SYSTEM; HEREDITY; HUMAN; LABORATORY TEST; MAJOR DEPRESSION; MONOTHERAPY; MOOD; PHARMACOGENETICS; PRIORITY JOURNAL; PSYCHODYNAMICS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; REASSURANCE; REVIEW; SCHIZOPHRENIA; SOCIAL ATTITUDE; SOCIAL STATUS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ATTITUDE TO HEALTH; CHILD; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MENTAL DISORDERS; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PSYCHIATRY; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84857414782     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2011.11.007     Document Type: Review

References (35)

1. Voelker R. New tool to gauge depression remission focuses on good feelings, not bad ones. JAMA 2011, 306(4):363-364.
2. Pigott H.E., Leventhal A.M., Alter G.S., et al. Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 2010, 79(5):267-279.
3. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington (DC). 4th edition.
4. Aikens J.E., Kroenke K., Nease D.E., et al. Gen Hosp Psychiatry 2008, 30(1):26-31.
5. Weissman M.M., Pilowsky D.J., Wickramaratne P.J., et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA 2006, 295(12):1389-1398.
6. McIntyre R.S., O'Donovan C. The human cost of not achieving full remission in depression. Can J Psychiatry 2004, 49(3 Suppl 1):10S-16S.
7. Cramer S.C. Listening to fluoxetine: a hot message from the FLAME trial of poststroke recovery. Int J Stroke 2011, 6(4):315-316.
8. Pan A., Okereke O., Sun Q., et al. Depression and incident stroke in women. Stroke 2011, 42(10):2770-2775.
9. Leuchter A.F., Husain M.M., Cook I.A., et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychol Med 2010, 40(2):239-251.
10. Ozer E.J., Fernald L.C., Weber A., et al. Does alleviating poverty affect mothers' depressive symptoms?. A quasi-experimental investigation of Mexico's Oportunidades programme. Int J Epidemiol 2011, [Epub ahead of print].
11. Fava M., Rush A.J., Alpert J.E., et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008, 165(3):342-351.
12. Davis L.L., Frazier E., Husain M.M., et al. Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort. Am J Addict 2006, 15(4):278-285.
13. Howland R.H., Rush A.J., Wisniewski S.R., et al. Concurrent anxiety and substance use disorders among patients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend 2009, 1(1-3):248-260.
14. Mischoulon D., Eddy K.T., Keshaviah A., et al. Depression and eating disorders: treatment and course. J Affect Disord 2011, 130(3):470-477.
15. Sunderajan P., Gaynes B.N., Wisniewski S.R., et al. Insomnia in patients with depression: a STAR*D report. CNS Spectr 2010, 15(6):394-404.
16. Gulec M., Selvi Y., Boysan M., et al. Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: a 52-week follow-up study. J Affect Disord 2011, 134(1-3):257-265.
17. Brand S., Kirov R. Sleep and its importance in adolescence and in common adolescent somatic and psychiatric conditions. Int J Gen Med 2011, 4:425-442.
18. Schofield P., Crosland A., Waheed W. Patients' views of antidepressants: from first experiences to becoming expert. Br J Gen Pract 2011, 61(585):142-148.
19. Nierenberg A.A., Leon A.C., Price L.H., et al. Crisis of confidence: antidepressant risk versus benefit. J Clin Psychiatry 2011, 72(3):e11.
20. Najdowski C.J., Ullman S.E. The effects of revictimization on coping and depression in female sexual assault victims. J Trauma Stress 2011, 24(2):218-221.
21. Solhaug H.I., Romuld E.B., Romild U., et al. Increased prevalence of depression in cohorts of the elderly: an 11-year follow-up in the general population-the HUNT study. Int Psychogeriatr 2012, 24(1):151-158.
22. Sinyor M., Schaffer A., Levitt A. The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatry 2010, 55(3):126-135.
23. Daly E.J., Trivedi M.H., Wisniewski S.R., et al. Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry 2010, 22(1):43-55.
24. Shern D.L., Moran H. STAR*D: helping to close the gap between science and practice. Psychiatr Serv 2009, 60(11):1458-1459.
25. Gaynes B.N., Warden D., Trivedi M.H., et al. What did STAR*D teach us?. Results from a large-scale, practical clinical trial for patients with depression. Psychiatr Serv 2009, 60(11):1439-1445.
26. Rush A.J., Warden D., Wisniewski S.R., et al. STAR*D: revising conventional wisdom. CNS Drugs 2009, 23(8):627-647.
27. Rush A.J., Trivedi M.H., Wisniewski S.R., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163(11):1905-1917.
28. Binder E.B., Owens M.J., Liu W., et al. Association of polymorphisms in genes regulating the corticotrophin-releasing factor system with antidepressant treatment response. Arch Gen Psychiatry 2010, 67(4):369-379.
29. Laje G., Perlis R.H., Rush A.J., et al. Pharmacogenetics studies in STAR*D: strengths, limitations, and results. Psychiatr Serv 2009, 60(11):1446-1457.
30. DeBattista C., Kinrys G., Hoffman D., et al. The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. J Psychiatr Serv 2011, 45(1):64-75.
31. Kerestes R., Ladouceur C.D., Meda S., et al. Abnormal prefrontal activity subserving attentional control of emotion in remitted depressed patients during a working memory task with emotional distracters. Psychol Med 2012, 42(1):29-40.
32. Surget A., Tanti A., Leonardo E.D., et al. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry 2011, 16(12):1177-1188.
33. Haeffel G.J. Resilience to depressive symptoms: the buffering effects of enhancing cognitive style and positive life events. J Behav Ther Exp Psychiatry 2011, 42(1):13-18.
34. Tibaldi G., Salvador-Carulla L., Garcia-Gutierrez J.C. From treatment adherence to advanced shared decision making: new professional strategies and attitudes in mental health care. Curr Clin Pharmacol 2011, 6(2):91-99.
35. Nease D.E., Aikens J.E., Klinkman M.S., et al. Toward a more comprehensive assessment of depression remission: the Remission Evaluation and Mood Inventory Tool (REMIT). Gen Hosp Psychiatry 2011, 33(3):279-286.